COST ANALYSIS OF TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME IN RUSSIA

被引：0
|
作者：
Pyadushkina, E. A. [1 ]
Gerasimova, K., V [2 ]
Avxentyeva, M. [1 ]
Krysanov, I [1 ]
机构：
[1] Russian Natl Res Med Univ, Res Ctr Clin & Econ Evaluat & Pharmacoecon, Moscow, Russia
[2] First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.969
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A366 / A366
页数：1
相关论文
共 50 条
  • [1] COST EFFECTIVENESS ANALYSIS OF TICAGRELOR VERSUS GENERIC CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN SPAIN
    Capel, M.
    Lopez-Sendon, J. L.
    Heras, M.
    Carrera, F. J.
    Brosa, M.
    VALUE IN HEALTH, 2014, 17 (07) : A491 - A491
  • [2] Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis
    Chen, Yundai
    Dong, Wei
    Wan, Zheng
    Li, Zhanquan
    Cong, Hongliang
    Hong, Tao
    Yin, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 545 - 546
  • [3] Ticagrelor versus Clopidogrel: Two Controversial Drugs in Patients with Acute Coronary Syndrome
    Mo, De-Gang
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [4] Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
    Wallentin, Lars
    Becker, Richard C.
    Budaj, Andrzej
    Cannon, Christopher P.
    Emanuelsson, Hakan
    Held, Claes
    Horrow, Jay
    Husted, Steen
    James, Stefan
    Katus, Hugo
    Mahaffey, Kenneth W.
    Scirica, Benjamin M.
    Skene, Allan
    Steg, Philippe Gabriel
    Storey, Robert F.
    Harrington, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1045 - 1057
  • [5] CLINICAL OUTCOMES OF CLOPIDOGREL VERSUS TICAGRELOR IN THE ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROME
    Fan, Lampson
    Shabbir, Asad
    Mclure, Stewart
    Lam, Jocelyn
    Cassar, Mark
    Spyrou, Nicos
    HEART, 2017, 103 : A52 - A52
  • [6] COST-EFFECTIVENESS OF TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO STUDY: A CANADIAN ANALYSIS
    Mittmann, N.
    Chan, B.
    Seung, S. J.
    Liovas, A.
    Cohen, E.
    VALUE IN HEALTH, 2011, 14 (07) : A378 - A379
  • [7] COST-EFECTIVENESS OF GENOTYPE/PHENOTYPE DRIVEN TICAGRELOR VERSUS CLOPIDOGREL SELECTION IN THE PATIENTS WITH ACUTE CORONARY SYNDROME
    Kim, Kibum
    Ardati, Amer
    DiDomenico, Robert
    Cavallari, Larisa
    Touchette, Daniel R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A24 - A24
  • [8] Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
    Grima, Daniel T.
    Brown, Stephen T.
    Kamboj, Laveena
    Bainey, Kevin R.
    Goeree, Ron
    Oh, Paul
    Ramanathan, Krishnan
    Goodman, Shaun G.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 49 - 62
  • [9] Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
    Li, Yuzhuo
    Li, Jing
    Qiu, Miaohan
    Ma, Sicong
    Na, Kun
    Li, Xiaoying
    Qi, Zizhao
    Chen, Sanbao
    Li, Yi
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 : 1395 - 1402
  • [10] Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia
    Mejia, Aurelio
    Manuel, Juan, Sr.
    Ceballos, Mateo
    Atehortua, Sara
    Manuel Toro, Juan
    Saldarriaga, Clara
    Elena Mejia, Maria
    Ramirez, Carolina
    BIOMEDICA, 2015, 35 (04): : 531 - 540
12345